Acute dystonia with thalamic and brainstem lesions after initial penicillamine treatment in Wilson's disease

European Neurology

Volumn 39, Issue 1, 1998, Pages 32-37

  Huang, Chin Chang ^a,b   Chu, Nai Shin ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Akinetic rigid syndrome; Dystonia; Penicillamine; Wilson's disease

Indexed keywords

CHELATING AGENT; PENICILLAMINE; ZINC SULFATE;

ADOLESCENT; ADULT; ARTICLE; BASAL GANGLION; BRAIN STEM INJURY; CASE REPORT; DYSTONIA; FEMALE; HUMAN; MALE; MUSCLE RIGIDITY; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TEGMENTUM; THALAMUS; WILSON DISEASE;

ADOLESCENT; ADULT; BRAIN STEM; DYSTONIA; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PENICILLAMINE; THALAMIC DISEASES;

EID: 0031963183     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007894     Document Type: Article

References (26)

1. Marsden CD, Obeso JA, Zarranz JJ, Lang AE: The anatomical basis symptomatic hemidystonia. Brain 1985;108:463-483.
2. Steele JC, Richardson JC, Olszewski J: Progressive supranuclear palsy. Arch Neurol 1964; 10:333-359.
3. Kurlan R, Shoulson I: Dystonia and akinetic rigid features in central pontine myelinolysis. Ann Neurol 1989;26:141.
4. Tison FX, Ferrer X, Julien J: Delayed onset movement disorders as a complication of central pontine myelinolysis. Mov Disord 1991;6: 171-173.
5. Starosta-Rubinstein S, Young AB, Kluin K, Hill G, Aisen AM, Gabvielsen T, Brewer GJ: Clinical assessment of 31 patients with Wilson's disease. Correlations with structural changes on magnetic resonance imaging. Arch Neurol 1987;44:365-377.
6. Oder W, Grimm G, Kollegger H, Ferenci P, Schneider B, Deecke L: Neurological and neuropsychiatic spectrum of Wilson's disease: A prospective study of 45 cases. J Neurol 1996; 243:269-273.
7. Leibell RL, Shih VE, Goodman SI, et al: Glutaric acidemia: a metabolic disorder causing progressive choreoathetosis. Neurology 1980; 30:1163-1168.
8. Fink JK, Filling-Katz MR, Sokol J, et al: Clinical spectrum of Niemann-Pick disease type C. Neurology 1989;39:1040-1049.
9. Yoshida K, Akihiro O, Sakiraba H, et al: GMI gangliosidosis in adults: Clinical and molecular analysis of 16 Japanese patients. Ann Neurol 1992;31:328-332.
10. Gibbs WRG, Lee AJ, Marsden CD: Pathological report of four patients presenting with cranial dystonias. Mov Disord 1988;3:211-221.
11. Jankovic J, Patel SC: Blepharospasm associated with brainstem lesions. Neurology 1983;33: 1237-1240.
12. Janati A: Progressive supranuclear palsy: Report of a case with torticollis, blepharospasm and dysfluency. Am J Med Sci 1986;292:391-392.
13. Grafton ST, Bahls FH, Bell KR: Acquired focal dystonia following recovery from central pontine myelinolysis. J Neurol Neurosurg Psychiatry 1988;51:1354-1355.
14. Zweig RM, Hedreen JC, Jankel WR, Casanova MF, Whitehouse PJ, Price DL: Pathology in brainstem regions of individuals with primary dystonia. Neurology 1988;38:702-706.
15. Hitoshi S, Iwata M, Yoshikawa K: Midbrain pathology of Wilson's disease: MRI analysis of three cases. J Neurol Neurosurg Psychiatry 1991;54:624-626.
16. Castan P: La myélinolyse centrale dans la dégénérescence hépato-lenticulaire. Essai sur la signification. Revue Neurol (Paris) 1967;117: 391-409.
17. Burguera JA, Catala J, Casanova B: Thalamic demyelination and paroxysmal dystonia in multiple sclerosis. Mov Disord 1991;6:379-383.
18. Brewer GJ, Terry CA, Aisen AM, Hill GM: Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy. Arch Neurol 1987;44:490-493.
19. Walshe JM: Wilson's disease (hepatolenticular degeneration); in Vinken PJ, Bruyn GW, Klawans HL (eds): Handbook of Clinical Neurology, vol 27. Metabolic and Deficiency Diseases of the Nervous System. Amsterdam, North Holland, 1976, pp 379-414.
20. Huang CC, Chu NS: Wilson's disease: resolution of MRI lesions following long-term oral zinc therapy. Acta Neurol Scand 1996;93:215-218.
21. Brewer GJ, Dick RD, Johnson V, et al: Treatment of Wilson's disease with ammonium tetrathiomolybdate: Initial therapy in 17 neurologically affected patients. Arch Neurol 1994; 51:545-554.
22. Czlonkowska A, Gajda J, Rodo M: Effects of long term treatment in Wilson's disease with d-penicillamine and zinc sulphate. J Neurol 1996;243:269-273.
23. Leu ML, Strickland T, Yeh SJ: Tissue copper, zinc and manganese levels in Wilson's disease: Studies with the use of neutron activation analysis. J Lab Clin Med 1971;77:438-444.
24. Gooneratne SR, Howell JMcC, Gawthorne JM: Intravenous administration of thiomolybdate for the prevention and treatment of chronic copper poisoning in sheep. Br J Neutr 1981;46:457-467.
25. Cumings JN: The copper and iron content of brain and liver in the normal and in hepatolenticular degeneration. Brain 1948;71:410-415.
26. Huang CC, Chu NS: Psychosis and epileptic seizures in Wilson's disease with predominantly white matter lesions in the frontal lobe. Parkinson Relat Disord 1995;1:53-58.